Challenges in IBD Research: Novel Technologies

Manish Dhyani, Nitin Joshi, Willem A. Bemelman, Michael S. Gee, Vijay Yajnik, André D'Hoore, Giovanni Traverso, Mark Donowitz, Gustavo Mostoslavsky, Timothy K. Lu, Neil Lineberry, Heiko G. Niessen, Dan Peer, Jonathan Braun, Conor P. Delaney, Marla C. Dubinsky, Ashley Guillory, Maria Pereira, Nataly Shtraizent, Gerard HonigDavid Brent Polk, Andrés Hurtado-Lorenzo, Jeffrey M. Karp, Fabrizio Michelassi

Research output: Contribution to journalArticle

Abstract

Novel technologies is part of five focus areas of the Challenges in IBD research document, which also includes preclinical human IBD mechanisms, environmental triggers, precision medicine and pragmatic clinical research. The Challenges in IBD research document provides a comprehensive overview of current gaps in inflammatory bowel diseases (IBD) research and delivers actionable approaches to address them. It is the result of a multidisciplinary input from scientists, clinicians, patients, and funders, and represents a valuable resource for patient centric research prioritization. In particular, the novel technologies section is focused on prioritizing unmet clinical needs in IBD that will benefit from novel technologies applied to: 1) non-invasive detection and monitoring of active inflammation and assessment of treatment response; 2) mucosal targeted drug delivery systems; and 3) prevention of post-operative septic complications and treatment of fistulizing complications. Proposed approaches include development of multiparametric imaging modalities and biosensors, to enable non invasive or minimally invasive detection of pro-inflammatory signals to monitor disease activity and treatment responses. Additionally, technologies for local drug delivery to control unremitting disease and increase treatment efficacy while decreasing systemic exposure are also proposed. Finally, research on biopolymers and other sealant technologies to promote post-surgical healing; and devices to control anastomotic leakage and prevent post-surgical complications and recurrences are also needed.

Original languageEnglish (US)
Pages (from-to)S24-S30
JournalInflammatory bowel diseases
Volume25
Issue number2
DOIs
StatePublished - May 16 2019

Fingerprint

Inflammatory Bowel Diseases
Technology
Research
Precision Medicine
Anastomotic Leak
Biopolymers
Biosensing Techniques
Drug Delivery Systems
Therapeutics
Inflammation
Recurrence
Equipment and Supplies
Pharmaceutical Preparations

Keywords

  • anastomosis
  • Crohn’s disease
  • drug delivery
  • fistula
  • non-invasive imaging
  • radiology
  • sepsis
  • surgery
  • ulcerative colitis

ASJC Scopus subject areas

  • Immunology and Allergy
  • Gastroenterology

Cite this

Dhyani, M., Joshi, N., Bemelman, W. A., Gee, M. S., Yajnik, V., D'Hoore, A., ... Michelassi, F. (2019). Challenges in IBD Research: Novel Technologies. Inflammatory bowel diseases, 25(2), S24-S30. https://doi.org/10.1093/ibd/izz077

Challenges in IBD Research : Novel Technologies. / Dhyani, Manish; Joshi, Nitin; Bemelman, Willem A.; Gee, Michael S.; Yajnik, Vijay; D'Hoore, André; Traverso, Giovanni; Donowitz, Mark; Mostoslavsky, Gustavo; Lu, Timothy K.; Lineberry, Neil; Niessen, Heiko G.; Peer, Dan; Braun, Jonathan; Delaney, Conor P.; Dubinsky, Marla C.; Guillory, Ashley; Pereira, Maria; Shtraizent, Nataly; Honig, Gerard; Polk, David Brent; Hurtado-Lorenzo, Andrés; Karp, Jeffrey M.; Michelassi, Fabrizio.

In: Inflammatory bowel diseases, Vol. 25, No. 2, 16.05.2019, p. S24-S30.

Research output: Contribution to journalArticle

Dhyani, M, Joshi, N, Bemelman, WA, Gee, MS, Yajnik, V, D'Hoore, A, Traverso, G, Donowitz, M, Mostoslavsky, G, Lu, TK, Lineberry, N, Niessen, HG, Peer, D, Braun, J, Delaney, CP, Dubinsky, MC, Guillory, A, Pereira, M, Shtraizent, N, Honig, G, Polk, DB, Hurtado-Lorenzo, A, Karp, JM & Michelassi, F 2019, 'Challenges in IBD Research: Novel Technologies', Inflammatory bowel diseases, vol. 25, no. 2, pp. S24-S30. https://doi.org/10.1093/ibd/izz077
Dhyani M, Joshi N, Bemelman WA, Gee MS, Yajnik V, D'Hoore A et al. Challenges in IBD Research: Novel Technologies. Inflammatory bowel diseases. 2019 May 16;25(2):S24-S30. https://doi.org/10.1093/ibd/izz077
Dhyani, Manish ; Joshi, Nitin ; Bemelman, Willem A. ; Gee, Michael S. ; Yajnik, Vijay ; D'Hoore, André ; Traverso, Giovanni ; Donowitz, Mark ; Mostoslavsky, Gustavo ; Lu, Timothy K. ; Lineberry, Neil ; Niessen, Heiko G. ; Peer, Dan ; Braun, Jonathan ; Delaney, Conor P. ; Dubinsky, Marla C. ; Guillory, Ashley ; Pereira, Maria ; Shtraizent, Nataly ; Honig, Gerard ; Polk, David Brent ; Hurtado-Lorenzo, Andrés ; Karp, Jeffrey M. ; Michelassi, Fabrizio. / Challenges in IBD Research : Novel Technologies. In: Inflammatory bowel diseases. 2019 ; Vol. 25, No. 2. pp. S24-S30.
@article{7b4f4ff836b64d1d993944e9e5aebe74,
title = "Challenges in IBD Research: Novel Technologies",
abstract = "Novel technologies is part of five focus areas of the Challenges in IBD research document, which also includes preclinical human IBD mechanisms, environmental triggers, precision medicine and pragmatic clinical research. The Challenges in IBD research document provides a comprehensive overview of current gaps in inflammatory bowel diseases (IBD) research and delivers actionable approaches to address them. It is the result of a multidisciplinary input from scientists, clinicians, patients, and funders, and represents a valuable resource for patient centric research prioritization. In particular, the novel technologies section is focused on prioritizing unmet clinical needs in IBD that will benefit from novel technologies applied to: 1) non-invasive detection and monitoring of active inflammation and assessment of treatment response; 2) mucosal targeted drug delivery systems; and 3) prevention of post-operative septic complications and treatment of fistulizing complications. Proposed approaches include development of multiparametric imaging modalities and biosensors, to enable non invasive or minimally invasive detection of pro-inflammatory signals to monitor disease activity and treatment responses. Additionally, technologies for local drug delivery to control unremitting disease and increase treatment efficacy while decreasing systemic exposure are also proposed. Finally, research on biopolymers and other sealant technologies to promote post-surgical healing; and devices to control anastomotic leakage and prevent post-surgical complications and recurrences are also needed.",
keywords = "anastomosis, Crohn’s disease, drug delivery, fistula, non-invasive imaging, radiology, sepsis, surgery, ulcerative colitis",
author = "Manish Dhyani and Nitin Joshi and Bemelman, {Willem A.} and Gee, {Michael S.} and Vijay Yajnik and Andr{\'e} D'Hoore and Giovanni Traverso and Mark Donowitz and Gustavo Mostoslavsky and Lu, {Timothy K.} and Neil Lineberry and Niessen, {Heiko G.} and Dan Peer and Jonathan Braun and Delaney, {Conor P.} and Dubinsky, {Marla C.} and Ashley Guillory and Maria Pereira and Nataly Shtraizent and Gerard Honig and Polk, {David Brent} and Andr{\'e}s Hurtado-Lorenzo and Karp, {Jeffrey M.} and Fabrizio Michelassi",
year = "2019",
month = "5",
day = "16",
doi = "10.1093/ibd/izz077",
language = "English (US)",
volume = "25",
pages = "S24--S30",
journal = "Inflammatory Bowel Diseases",
issn = "1078-0998",
publisher = "John Wiley and Sons Inc.",
number = "2",

}

TY - JOUR

T1 - Challenges in IBD Research

T2 - Novel Technologies

AU - Dhyani, Manish

AU - Joshi, Nitin

AU - Bemelman, Willem A.

AU - Gee, Michael S.

AU - Yajnik, Vijay

AU - D'Hoore, André

AU - Traverso, Giovanni

AU - Donowitz, Mark

AU - Mostoslavsky, Gustavo

AU - Lu, Timothy K.

AU - Lineberry, Neil

AU - Niessen, Heiko G.

AU - Peer, Dan

AU - Braun, Jonathan

AU - Delaney, Conor P.

AU - Dubinsky, Marla C.

AU - Guillory, Ashley

AU - Pereira, Maria

AU - Shtraizent, Nataly

AU - Honig, Gerard

AU - Polk, David Brent

AU - Hurtado-Lorenzo, Andrés

AU - Karp, Jeffrey M.

AU - Michelassi, Fabrizio

PY - 2019/5/16

Y1 - 2019/5/16

N2 - Novel technologies is part of five focus areas of the Challenges in IBD research document, which also includes preclinical human IBD mechanisms, environmental triggers, precision medicine and pragmatic clinical research. The Challenges in IBD research document provides a comprehensive overview of current gaps in inflammatory bowel diseases (IBD) research and delivers actionable approaches to address them. It is the result of a multidisciplinary input from scientists, clinicians, patients, and funders, and represents a valuable resource for patient centric research prioritization. In particular, the novel technologies section is focused on prioritizing unmet clinical needs in IBD that will benefit from novel technologies applied to: 1) non-invasive detection and monitoring of active inflammation and assessment of treatment response; 2) mucosal targeted drug delivery systems; and 3) prevention of post-operative septic complications and treatment of fistulizing complications. Proposed approaches include development of multiparametric imaging modalities and biosensors, to enable non invasive or minimally invasive detection of pro-inflammatory signals to monitor disease activity and treatment responses. Additionally, technologies for local drug delivery to control unremitting disease and increase treatment efficacy while decreasing systemic exposure are also proposed. Finally, research on biopolymers and other sealant technologies to promote post-surgical healing; and devices to control anastomotic leakage and prevent post-surgical complications and recurrences are also needed.

AB - Novel technologies is part of five focus areas of the Challenges in IBD research document, which also includes preclinical human IBD mechanisms, environmental triggers, precision medicine and pragmatic clinical research. The Challenges in IBD research document provides a comprehensive overview of current gaps in inflammatory bowel diseases (IBD) research and delivers actionable approaches to address them. It is the result of a multidisciplinary input from scientists, clinicians, patients, and funders, and represents a valuable resource for patient centric research prioritization. In particular, the novel technologies section is focused on prioritizing unmet clinical needs in IBD that will benefit from novel technologies applied to: 1) non-invasive detection and monitoring of active inflammation and assessment of treatment response; 2) mucosal targeted drug delivery systems; and 3) prevention of post-operative septic complications and treatment of fistulizing complications. Proposed approaches include development of multiparametric imaging modalities and biosensors, to enable non invasive or minimally invasive detection of pro-inflammatory signals to monitor disease activity and treatment responses. Additionally, technologies for local drug delivery to control unremitting disease and increase treatment efficacy while decreasing systemic exposure are also proposed. Finally, research on biopolymers and other sealant technologies to promote post-surgical healing; and devices to control anastomotic leakage and prevent post-surgical complications and recurrences are also needed.

KW - anastomosis

KW - Crohn’s disease

KW - drug delivery

KW - fistula

KW - non-invasive imaging

KW - radiology

KW - sepsis

KW - surgery

KW - ulcerative colitis

UR - http://www.scopus.com/inward/record.url?scp=85066832557&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85066832557&partnerID=8YFLogxK

U2 - 10.1093/ibd/izz077

DO - 10.1093/ibd/izz077

M3 - Article

C2 - 31095703

AN - SCOPUS:85066832557

VL - 25

SP - S24-S30

JO - Inflammatory Bowel Diseases

JF - Inflammatory Bowel Diseases

SN - 1078-0998

IS - 2

ER -